A critical evaluation of cryoprecipitate for replacement of fibrinogen

British Journal of Haematology

Volumn 149, Issue 6, 2010, Pages 834-843

  Sørensen, Benny ^a   Bevan, David ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Acquired fibrinogen deficiency; Congenital fibrinogen deficiency; Cryoprecipitate; Fibrinogen concentrate; Perioperative bleeding

Indexed keywords

BLOOD CLOTTING FACTOR; FIBRINOGEN; FRESH FROZEN PLASMA; HAEMOCOMPLETTAN; UNCLASSIFIED DRUG;

BLEEDING; BLOOD DONOR; COMPARATIVE STUDY; COST; CRYOPRECIPITATE; DISEASE TRANSMISSION; DRUG EFFICACY; FIBRIN POLYMERIZATION; FIBRINOGEN BLOOD LEVEL; HEMOPHILIA; HUMAN; IMMUNE MEDIATED INJURY; PASTEURIZATION; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN PURIFICATION; REVIEW; VIRUS INACTIVATION;

AFIBRINOGENEMIA; BLOOD LOSS, SURGICAL; FIBRINOGEN; HEMOPHILIA A; HEMOSTASIS, SURGICAL; HUMANS; MALE; PLASMA;

EID: 77952688542     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08208.x     Document Type: Review

References (86)

1. Ahrons, S., Glavind-Kristensen, S., Drachmann, O. Kissmeyer-Nielsen, F. (1970) Severe reactions after cryoprecipitated human factor VIII. Vox Sanguinis, 18, 182 184.
2. Alter, H.J. Klein, H.G. (2008) The hazards of blood transfusion in historical perspective. Blood, 112, 2617 2626.
3. Atance, R., Pereira, A. Ramirez, B. (2001) Transfusing methylene blue-photoinactivated plasma instead of FFP is associated with an increased demand for plasma and cryoprecipitate. Transfusion, 41, 1548 1552.
4. Aygoren-Pursun, E., Martinez Saguer, I., Rusicke, E., Louwen, F., Geka, F., Ivaskevicius, V., Oldenburg, J., Klingebiel, T. Kreuz, W. (2007) Retrochorionic hematoma in congenital afibrinogenemia: resolution with fibrinogen concentrate infusions. American Journal of Hematology, 82, 317 320.
5. Aznar, J.A., Bonanad, S., Montoro, J.M., Hurtado, C., Cid, A.R., Soler, M.A. De Miguel, A. (2000) Influence of methylene blue photoinactivation treatment on coagulation factors from fresh frozen plasma, cryoprecipitates and cryosupernatants. Vox Sanguinis, 79, 156 160.
6. Balleisen, L., Bailey, J., Epping, P.H., Schulte, H. van de Loo, J. (1985) Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause. Thrombosis and Haemostasis, 54, 475 479. (Pubitemid 16255676)
7. Bevan, D.H. (1999) Cardiac bypass haemostasis: putting blood through the mill. British Journal of Haematology, 104, 208 219.
8. Blome, M., Isgro, F., Kiessling, A.H., Skuras, J., Haubelt, H., Hellstern, P. Saggau, W. (2005) Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thrombosis and Haemostasis, 93, 1101 1107.
9. Bronnimann, R. (1954) [Congenital afibrinogenemia; report of a case with multiple bone cysts and formation of a specific antibody (anti fibrinogen) following blood transfusion.]. Acta Haematologica, 11, 40 51.
10. Bundesaertzekammer/German Medical Association 2009) Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives, 4th edn. Available from: http://www.bundesaerztekammer.de/page.asp?his=0.6.3288.6716 (Accessed March 2010).
11. Cardigan, R., Philpot, K., Cookson, P. Luddington, R. (2009) Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate. Transfusion, 49, 696 703.
12. Chapman, C.E., Stainsby, D., Jones, H., Love, E., Massey, E., Win, N., Navarrete, C., Lucas, G., Soni, N., Morgan, C., Choo, L., Cohen, H. Williamson, L.M. (2008) Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion, 49, 440 452.
13. Charbit, B., Mandelbrot, L., Samain, E., Baron, G., Haddaoui, B., Keita, H., Sibony, O., Mahieu-Caputo, D., Hurtaud-Roux, M.F., Huisse, M.G., Denninger, M.H. de Prost, D. (2007) The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. Journal of Thrombosis and Haemostasis, 5, 266 273.
14. Chowdhury, P., Saayman, A.G., Paulus, U., Findlay, G.P. Collins, P.W. (2004) Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. British Journal of Haematology, 125, 69 73.
15. Ciavarella, D., Reed, R.L., Counts, R.B., Baron, L., Pavlin, E., Heimbach, D.M. Carrico, C.J. (1987) Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. British Journal of Haematology, 67, 365 368.
16. Coppola, L., Caserta, F., De Lucia, D., Guastafierro, S., Grassia, A., Coppola, A., Marfella, R. Varricchio, M. (2000) Blood viscosity and aging. Archives of Gerontology and Geriatrics, 31, 35 42.
17. Danes, A.F., Cuenca, L.G., Bueno, S.R., Mendarte Barrenechea, L. Ronsano, J.B. (2008) Efficacy and tolerability of human fibrinogen concentrate administration to patients with acquired fibrinogen deficiency and active or in high-risk severe bleeding. Vox Sanguinis, 94, 221 226.
18. De Vries, A., Rosenberg, T., Kochwa, S. Boss, J.H. (1961) Precipitating antifibrinogen antibody appearing after fibrinogen infusions in a patient with congenital afibrinogenemia. American Journal of Medicine, 30, 486 494.
19. Dickneite, G., Joch, C. Bergman, G.E. (2008) The evaluation of a prothrombotic risk in a human fibrinogen concentrate. Blood (American Society of Hematology Annual Meeting Abstracts), 112, 4064.
20. Dietrich, W. (2000) Cardiac surgery and the coagulation system. Current Opinion in Anaesthesiology, 13, 27 34.
21. Elodi, S. Varadi, K. (1979) Optimization of conditions for the catalytic effect of the factor IXa-factor VIII complex: probable role of the complex in the amplification of blood coagulation. Thrombosis Research, 15, 617 629.
22. Fenger-Eriksen, C., Lindberg-Larsen, M., Christensen, A.Q., Ingerslev, J. Sorensen, B. (2008) Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. British Journal of Anaesthesia, 101, 769 773.
23. Fenger-Eriksen, C., Tonnesen, E., Ingerslev, J. Sorensen, B. (2009a) Mechanisms of hydroxyethyl starch-induced dilutional coagulopathy. Journal of Thrombosis and Haemostasis, 7, 1099 1105.
24. Fenger-Eriksen, C., Midtgaard Jensen, T., Kristensen, B.S., Jensen, K.M., Tonnesen, E., Ingerslev, J. Sorensen, B. (2009b) Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized placebo-controlled clinical trial. Journal of Thrombosis and Haemostasis, 7, 795 802.
25. Fenger-Erikson, C., Ingerslev, J. Sorenson, B. (2009c) Fibrinogen concentrate - a potential universal haemostatic agent. Expert Opinion on Biological Therapy, 9, 1325 1333.
26. Flamholz, R., Jeon, H.R., Baron, J.M. Baron, B.W. (2000) Study of three patients with thrombotic thrombocytopenic purpura exchanged with solvent/detergent-treated plasma: is its decreased protein S activity clinically related to their development of deep venous thromboses? Journal of Clinical Apheresis, 15, 169 172.
27. Fries, D., Innerhofer, P., Klingler, A., Berresheim, U., Mittermayr, M., Calatzis, A. Schobersberger, W. (2002) The effect of the combined administration of colloids and lactated Ringer's solution on the coagulation system: an in vitro study using thrombelastograph coagulation analysis (ROTEG). Anesthesia and Analgesia, 94, 1280 1287.
28. Fries, D., Krismer, A., Klingler, A., Streif, W., Klima, G., Wenzel, V., Haas, T. Innerhofer, P. (2005) Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. British Journal of Anaesthesiology, 95, 172 177.
29. Fries, D., Haas, T., Klingler, A., Streif, W., Klima, G., Martini, J., Wagner-Berger, H. Innerhofer, P. (2006) Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathy - a porcine model. British Journal of Anaesthesia, 97, 460 467.
30. Gorlinger, K. (2006) Coagulation management during liver transplantation. Hamostaseologie, 26, S64 S76.
31. Groner, A. (2008) Reply. Pereira A. Cryoprecipitate versus commercial fibrinogen concentrate in patients who occasionally require a therapeutic supply of fibrinogen: risk comparison in the case of an emerging transfusion- transmitted infection. (Haematologica 2007;92:846-9). Haematologica, 93, e24 e26.
32. Haas, T., Fries, D., Velik-Salchner, C., Oswald, E. Innerhofer, P. (2008) Fibrinogen in craniosynostosis surgery. Anesthesia and Analgesia, 106, 725 731.
33. Heim, M.U., Meyer, B. Hellstern, P. (2009) Recommendations for the use of therapeutic plasma. Current Vascular Pharmacology, 7, 110 119.
34. Heimburger, N. (2002) From cryoprecipitate to virus-safe high-purity concentrate. Seminars in Thrombosis and Hemostasis, 28 (Suppl 1 25 30.
35. Heindl, B., Delorenzo, C. Spannagl, M. (2005) [High dose fibrinogen administration for acute therapy of coagulopathy during massive perioperative transfusion]. Anaesthesia, 54, 787 790.
36. Henkel-Honke, T. Oleck, M. (2007) Artificial oxygen carriers: a current review. AANA Journal, 75, 205 211.
37. Hiippala, S.T. (1995) Dextran and hydroxyethyl starch interfere with fibrinogen assays. Blood Coagulation & Fibrinolysis, 6, 743 746.
38. Hiippala, S.T., Myllyla, G.J. Vahtera, E.M. (1995) Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesthesia and Analgesia, 81, 360 365.
39. Hornsey, V.S., Krailadsiri, P., MacDonald, S., Seghatchian, J., Williamson, L.M. Prowse, C.V. (2000) Coagulation factor content of cryoprecipitate prepared from methylene blue plus light virus-inactivated plasma. British Journal of Haematology, 109, 665 670.
40. Innerhofer, P., Fries, D., Margreiter, J., Klingler, A., Kuhbacher, G., Wachter, B., Oswald, E., Salner, E., Frischhut, B. Schobersberger, W. (2002) The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesthesia and Analgesia, 95, 858 865.
41. Ishikawa, S., Kario, K., Nago, N., Kayaba, K., Hiraoka, J., Matsuo, H., Goto, T., Miyamoto, T., Tsutsumi, A., Nakamura, Y., Shimada, K., Inoue, K. Igarashi, M. (1997) Factor VII and fibrinogen levels examined by age, sex, and other atherosclerotic risk factors in a Japanese population. The Jichi Medical School Cohort Study. Thrombosis and Haemostasis, 77, 890 893.
42. Josephson, C.D. Abshire, T.C. (2006) Clinical uses of plasma and plasma fractions: plasma-derived products for hemophilias A and B, and for von Willebrand disease. Best Practice & Research. Clinical Haematology, 19, 35 49.
43. Karlsson, M., Ternstrom, L., Hyllner, M., Baghaei, F., Nilsson, S. Jeppsson, A. (2008) Plasma fibrinogen level, bleeding, and transfusion after on-pump coronary artery bypass grafting surgery: a prospective observational study. Transfusion, 48, 2152 2158.
44. Kestin, A.S., Valeri, C.R., Khuri, S.F., Loscalzo, J., Ellis, P.A., MacGregor, H., Birjiniuk, V., Ouimet, H., Pasche, B., Nelson, M.J., Benoit, S.E., Rodino, L.J., Barnard, M.R. Michelson, A.D. (1993) The platelet function defect of cardiopulmonary bypass. Blood, 82, 107 117.
45. Korte, W. Feldges, A. (1994) Increased prothrombin activation in a patient with congenital afibrinogenemia is reversible by fibrinogen substitution. The Clinical Investigator, 72, 396 398.
46. Kozek-Langenecker, S. (2007) Management of massive operative blood loss. Minerva Anestesiologica, 73, 401 415.
47. Kreuz, W., Meili, E., Peter-Salonen, K., Haertel, S., Devay, J., Krzensk, U. Egbring, R. (2005) Efficacy and tolerability of a pasteurised human fibrinogen concentrate in patients with congenital fibrinogen deficiency. Transfusion and Apheresis Science, 32, 247 253.
48. Laharrague, P.F., Cambus, J.P., Fillola, G. Corberand, J.X. (1993) Plasma fibrinogen and physiological aging. Aging (Milano), 5, 445 449.
49. Lambrecht, B., Mohr, H., Knüver-Hopf, J. Schmitt, H. (1991) Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light. Vox Sanguinis, 60, 207 213.
50. Li, Y.F., Spencer, F.A. Becker, R.C. (2001) Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa (alphaIIb/beta3) receptor-directed platelet inhibition. American Heart Journal, 142, 204 210.
51. MacLennan, S. Barbara, J.A. (2006) Risks and side effects of therapy with plasma and plasma fractions. Best Practice & Research Clinical Haematology, 19, 169 189.
52. Mardel, S.N., Saunders, F.M., Allen, H., Menezes, G., Edwards, C.M., Ollerenshaw, L., Baddeley, D., Kennedy, A. Ibbotson, R.M. (1998) Reduced quality of clot formation with gelatin-based plasma substitutes. British Journal of Anaesthesia, 80, 204 207.
53. Martini, W.Z., Pusateri, A.E., Uscilowicz, J.M., Delgado, A.V. Holcomb, J.B. (2005) Independent contributions of hypothermia and acidosis to coagulopathy in swine. Journal of Trauma, 58, 1002 1009.
54. Mittermayr, M., Streif, W., Haas, T., Fries, D., Velik-Salchner, C., Klingler, A., Oswald, E., Bach, C., Schnapka-Koepf, M. Innerhofer, P. (2007) Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration. Anesthesia and Analgesia, 105, 905 917.
55. Mosesson, M.W. (2003) Antithrombin I. Inhibition of thrombin generation in plasma by fibrin formation. Thrombosis and Haemostasis, 89, 9 12.
56. Nielsen, V.G., Cohen, B.M. Cohen, E. (2005) Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII. Acta anaesthesiologica Scandinavica, 49, 222 231.
57. Nizzi, F.A., Sapatnekar, S. Blick, R.L. (2002) Hereditary coagulation protein defects. In : Disorders of thrombosis and haemostasis (ed. by R.L., Blick). pp. 117 138. Lippincott Williams & Wilkins
58. O'Shaughnessy, D.F., Atterbury, C., Bolton Maggs, P., Murphy, M., Thomas, D., Yates, S. Williamson, L.M. (2004) Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. British Journal of Haematology, 126, 11 28.
59. Oswald, M.W., Hunt, H.H. Lazarchick, J. (1983) Normal range of plasma fibrinogen. The American Journal of Medical Technology, 49, 57 59.
60. Pincock, S. (2004) Patient's death from vCJD may be linked to blood transfusion. Committee to discuss need for further precautions to prevent possible vCJD transmission through blood. Lancet, 363, 43.
61. Pool, J.G. Shannon, A.E. (1965) Production of high-potency concentrates of antihemophilic globulin in a closed-bag system. New England Journal of Medicine, 273, 1443 1447.
62. Pool, J.G., Gershgold, E.J. Pappenhagen, A.R. (1964) High-potency antihaemophilic factor concentrate prepared from cryoglobulin precipitate. Nature, 203, 312.
63. Poon, M.C. (1993) Cryoprecipitate: uses and alternatives. Transfusion Medicine Reviews, 7, 180 192.
64. Pothula, S., Sanchala, V.T., Nagappala, B. Inchiosa, Jr., M.A. (2004) The effect of preoperative antiplatelet/anticoagulant prophylaxis on postoperative blood loss in cardiac surgery. Anesthesia and Analgesia, 98, 4 10. (Pubitemid 38029831)
65. Ra'anani, P., Levi, Y., Varon, D., Gitel, S. Martinowitz, U. (1991) [Congenital afibrinogenemia with bleeding, bone cysts and antibodies to fibrinogen]. Harefuah, 121, 291 293.
66. Rahe-Meyer, N., Solomon, C., Winterhalter, M., Piepenbrock, S., Tanaka, K., Haverich, A. Pichlmaier, M. (2009a) Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. Journal of Thoracic and Cardiovascular Surgery, 138, 694 702.
67. Rahe-Meyer, N., Pichlmaier, M., Haverich, A., Solomon, C., Winterhalter, M., Piepenbrock, S. Tanaka, K.A. (2009b) Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. British Journal of Anaesthesia, 102, 785 792.
68. Reese, E.P., McCullough, J.J. Craddock, P.R. (1975) An adverse pulmonary reaction to cryoprecipitate in a hemophiliac. Transfusion, 15, 583.
69. Reinhart, W.H. (2003) Fibrinogen-marker or mediator of vascular disease? Vascular Medicine, 8, 211 216.
70. Rodriguez, R.C., Buchanan, G.R. Clanton, M.S. (1988) Prophylactic cryoprecipitate in congenital afibrinogenemia. Clinical Pediatrics, 27, 543 545.
71. Royston, D. von Kier, S. (2001) Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. British Journal of Anaesthesia, 86, 575 578.
72. Seghatchian, J. Krailadsiri, P. (2001) What's happening? The quality of methylene blue treated FFP and cryo Transfusion and Apheresis Science, 25, 227 231.
73. Shore-Lesserson, L., Manspeizer, H.E., DePerio, M., Francis, S., Vela-Cantos, F. Ergin, M.A. (1999) Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesthesia and Analgesia, 88, 312 319.
74. Spalding, G.J., Hartrumpf, M., Sierig, T., Oesberg, N., Kirschke, C.G. Albes, J.M. (2007) Cost reduction of perioperative coagulation management in cardiac surgery: value of "bedside" thrombelastography (ROTEM). European Journal of Cardiothoracic Surgery, 31, 1052 1057.
75. Stainsby, D., MacLennan, S., Thomas, D., Isaac, J. Hamilton, P.J. (2006) Guidelines on the management of massive blood loss. British Journal of Haematology, 135, 634 641.
76. Stanworth, S.J. (2007) The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy. Hematology. American Society of Hematology Educational Program, 2007, 179 186.
77. Starr, D. (2002) Blood: An Epic History of Medicine and Commerce. Harper Collins
78. Stinger, H.K., Spinella, P.C., Perkins, J.G., Grathwohl, K.W., Salinas, J., Martini, W.Z., Hess, J.R., Dubick, M.A., Simon, C.D., Beekley, A.C., Wolf, S.E., Wade, C.E. Holcomb, J.B. (2008) The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. The Journal of Trauma, 64, S79 S85.
79. The Serious Hazards of Transfusion Steering Group 2004) Serious Hazards of Transfusion Annual Report 2004. Available from: http://www.shotuk.org/ SHOTREPORT2004.pdf (Accessed March 2010).
80. Ucar, H.I., Oc, M., Tok, M., Dogan, O.F., Oc, B., Aydin, A., Farsak, B., Guvener, M., Yorgancioglu, A.C., Dogan, R., Demircin, M. Pasaoglu, I. (2007a) Preoperative fibrinogen levels as a predictor of postoperative bleeding after open heart surgery. The Heart Surgery Forum, 10, E392 E396.
81. Ucar, H.I., Tok, M., Atalar, E., Dogan, O.F., Oc, M., Farsak, B., Guvener, M., Yilmaz, M., Dogan, R., Demircin, M. Pasaoglu, I. (2007b) Predictive significance of plasma levels of interleukin-6 and high-sensitivity C-reactive protein in atrial fibrillation after coronary artery bypass surgery. The Heart Surgery Forum, 10, E131 E135.
82. Velik-Salchner, C., Haas, T., Innerhofer, P., Streif, W., Nussbaumer, W., Klingler, A., Klima, G., Martinowitz, U. Fries, D. (2007) The effect of fibrinogen concentrate on thrombocytopenia. Journal of Thrombosis and Haemostasis, 5, 1019 1025.
83. Wallis, J.P. (2003) Transfusion-related acute lung injury (TRALI) - under-diagnosed and under-reported. British Journal of Anaesthesia, 90, 573 576.
84. Weinkove, R. Rangarajan, S. (2008) Fibrinogen concentrate for acquired hypofibrinogenaemic states. Transfusion Medicine, 18, 151 157.
85. Williamson, L.M., Cardigan, R. Prowse, C.V. (2003) Methylene blue-treated fresh-frozen plasma: what is its contribution to blood safety? Transfusion, 43, 1322 1329.
86. World Federation of Hemophilia 2005) Guidelines for the Management of Haemophilia. Available from: http://www.wfh.org/2/docs/Publications/Diagnosis- and-Treatment/Gudelines-Mng-Hemophilia.pdf (Accessed March 2010).